CSCI COSCIENS Biopharma Inc.

5.767USD8.250 CAD · TSX-4.07%Mkt Cap: 5.75M USDP/E: —

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally…

Key Statistics

Company
Market Cap5.75M USD
Enterprise Value9.17M USD
Revenue (TTM)9.76M USD
Gross Profit2.65M USD
Net Income (TTM)-10.36M USD
Revenue/Share9.34 USD
Last Price5.767 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees28
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA22112H2000
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.94
EV/Revenue0.94
P/S0.84
P/B0.54
EPS (TTM)-5.69 USD
EPS (Forward)—
52W Range
4.8934% of range27.68
52W High27.68 USD
52W Low4.893 USD
Profitability
Gross Margin35.30%
Oper. Margin-56.05%
EBITDA Margin-45.74%
Profit Margin-138.14%
ROE-269.60%
ROA-48.33%
ROIC—
ROCE-58.17%
Growth
Revenue Growth69.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.47M USD
CapEx (TTM)706.00K USD
FCF Margin52.24%
FCF Yield88.64%
Net Debt4.88M USD
Net Debt/EBITDA-1.09
Net Debt/FCF0.96
Balance Sheet
Debt/Equity0.56
Current Ratio0.66
Quick Ratio0.51
Book Value/Sh15.20 USD
Cash/Share9.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 2, 2007
Splits
Last Split50:150
Split DateJul 7, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.997.22K
Float992.22K
Insiders30.02%
Institutions0.00%
Short Interest
Short Ratio1.1d
Short % Float0.05%
Short % Out.0.05%
Shares Short532
Short (prev mo.)379
Technical
SMA 505.946 (-3.0%)
SMA 20011.03 (-47.7%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)472
Avg Vol (10d)390
Technical Indicators
RSI (14)45.2
MACD-0.0970
MACD Signal-0.0557
MACD Hist.-0.0413
BB Upper6.254 USD
BB Middle5.956 USD
BB Lower5.658 USD
BB Width10.02%
ATR (14)0.1915 USD
Vol Ratio (20d)0.82x

About COSCIENS Biopharma (TSE: CSCI)

›

COSCIENS Biopharma (TSE: CSCI) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 28 employees.

The shares were at 8.250 CAD on 19 November 2026, down 71.1% over 52 weeks. Its 52-week range is 7.000 CAD to 39.60 CAD: the price is 79.2% below the high and 17.9% above the low.

Its market capitalisation is 8.23M CAD.

COSCIENS Biopharma reports return on equity of -269.6%, an operating margin of -56.0% and revenue up 69.7% year over year.

Its debt exceeds its cash by 4.88M USD, a debt-to-equity ratio of 0.56. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.